Research Paper Volume 15, Issue 6 pp 2136—2157
The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker
Figure 4. The relations between CDKN2A expression and infiltration levels of different kinds of immune cell in cancer. Red is a positive correlation and blue is a negative correlation.